TFF Pharmaceuticals Nachrichten und Aktivitäten
Führungskräfte
Siehe das Organigramm mit seine 11 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei TFF Pharmaceuticals
- Harlan Weisman, Vice Chairman of the Board and Chief Executive Off...
- Stephen Rocamboli, Director
- Robert Mills, Director
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von TFF Pharmaceuticals nachzuverfolgen.
Pharmazie
TFF Pharmaceuticals hat 1.834 Konkurrenten , einschließlich Pfizer (USA), Sanofi (Frankreich) und Eli Lilly (USA).
Popular M&A news in Pharmazie
- Imbria Pharmaceuticals hat gerade eine Spendenaktion von 58 Millionen Dollar angekündigt. (veröffentlicht am 10, April 2025).
- Clario hat NRx Pharmaceuticals erworben (veröffentlicht am 18, März 2025).
- Knight Therapeutics has announced the acquisition of Paladin Labs (veröffentlicht am 12, März 2025).
Andere vorgeschlagene Kontakte der Pharmazie branche
Nachrichten
Neueste Pressemitteilungen nach TFF Pharmaceuticals
- TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery | TFF Pharmaceuticals
- TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization | TFF Pharmaceuticals
- TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference | TFF Pharmaceuticals
- TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection | TFF Pharmaceuticals
- TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update | TFF Pharmaceuticals
- TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities | TFF Pharmaceuticals
- TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection | TFF Pharmaceuticals
- TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing | TFF Pharmaceuticals
- TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection | TFF Pharmaceuticals
- View more press releases Close
Social media about TFF Pharmaceuticals
- TFF Pharmaceuticals auf Wikipedia, Google News & Yahoo Finance
- TFF Pharmaceuticals auf LinkedIn, Twitter & YouTube
